Conference abstractPublished 18 May 2015
Melatonin, a potential biochemical biomarker, offers neuroprotection in models of newborn hypoxic-ischemic brain injury through the restoration of MT1 receptors
Brigham and Women’s Hospital, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We and other researchers have reported that melatonin plays neuroprotective role in a variety of neurological conditions including acute cerebral ischemia and chronic Huntington’s disease and Amyotrophic lateral sclerosis. However its role as a protective agent against newborn hypoxic-ischemic (H-I) brain injury is not yet well studied, while the mechanisms by which melatonin causes neuroprotection in neurological diseases is still evolving. The present study demonstrated that there was significant reduction in MT1 receptors in ischemic brain in mouse pups in vivo with H-I brain injury and in primary cortical neurons and primary astrocytes in vitro as the result of environmental stress and melatonin offers protection through upregulation of MT1 receptors and inhibition of mitochondrial cell death pathways. The direct role of MT1 receptors was further supported by observation of increased mortality in MT1 knockout mice and the protective effects in neuronal cell death and the inhibitory role of mitochondrial cell death pathways including mitochondrial potential gradient dissipation, mitochondrial permeability transition pore opening, mitochondrial fragmentation, and inhibition of the subsequent cytochrome c/Smac/AIF releases and caspase-3 activation by melatonin were reversed by melatonin receptor antagonist luzindole. Moreover, we found that the serum levels of melatonin were reduced in newborn pups with H-I injury. Taken together, these data demonstrate that melatonin mediates its neuroprotective effect in models of newborn H-I brain injury, at least in part, by the restoration of MT1 receptors and the inhibition of mitochondrial cell death pathways and suggest that serum melatonin level may serve as a potential biochemical biomarker for this devastating newborn condition.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Xin Wang”
